NAVIDEA BIOPHARMACEUTICALS, INC. 4
4 · NAVIDEA BIOPHARMACEUTICALS, INC. · Filed May 5, 2017
Insider Transaction Report
Form 4
Latkin Jed
Interim COO
Transactions
- Award
Stock Option (Right to Buy)
2017-05-04+1,000,000→ 1,065,000 totalExp: 2027-05-04→ Common Stock (1,000,000 underlying)
Footnotes (1)
- [F1]333,334 options with a strike price of $0.65 will be exercisable on or after 5/4/2017, so long as the closing market price of the underlying common stock equals or exceeds $0.85 per share; 333,333 options with a strike price of $0.75 will be exercisable on or after 12/31/2017, so long as the closing market price of the underlying common stock equals or exceeds $1.00 per share; and 333,333 options with a strike price of $1.00 will be exercisable on or after 12/31/2018, so long as the closing market price of the underlying common stock equals or exceeds $1.25 per share.